Peer Review History
| Original SubmissionJune 27, 2025 |
|---|
|
PONE-D-25-30751-->-->Does it hold weight? The perceived effects of contraceptive use on weight status in females: A Mixed-Methods Study-->-->PLOS ONE?> Dear Dr. Johnson, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 26 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Vandana Dabla Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please ensure that you refer to Figure 1 and 3 in your text as, if accepted, production will need this reference to link the reader to the figure. 3. We note that there is identifying data in the Supporting Information file “Data Submission.xlsx”. Due to the inclusion of these potentially identifying data, we have removed this file from your file inventory. Prior to sharing human research participant data, authors should consult with an ethics committee to ensure data are shared in accordance with participant consent and all applicable local laws. Data sharing should never compromise participant privacy. It is therefore not appropriate to publicly share personally identifiable data on human research participants. The following are examples of data that should not be shared: -Name, initials, physical address -Ages more specific than whole numbers -Internet protocol (IP) address -Specific dates (birth dates, death dates, examination dates, etc.) -Contact information such as phone number or email address -Location data -ID numbers that seem specific (long numbers, include initials, titled “Hospital ID”) rather than random (small numbers in numerical order) Data that are not directly identifying may also be inappropriate to share, as in combination they can become identifying. For example, data collected from a small group of participants, vulnerable populations, or private groups should not be shared if they involve indirect identifiers (such as sex, ethnicity, location, etc.) that may risk the identification of study participants. Additional guidance on preparing raw data for publication can be found in our Data Policy (https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data) and in the following article: http://www.bmj.com/content/340/bmj.c181.long. Please remove or anonymize all personal information (<specific identifying information in file to be removed>), ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set. Please note that spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file. 4. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: You are requested to read the reviewers comments carefully and submit the point wise reply against each raised query. For comments you do not agree and feel that the original submission is justified reference to your study, must also be replied in detail. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: Major Comments 1. Mixed-Methods Integration Gap: o While the authors adopt a sequential explanatory design (quantitative followed by qualitative), the integration of findings across methods is largely descriptive and lacks depth. There is limited evidence of how the qualitative interviews build upon or help explain specific patterns observed in the survey data. o Recommendation: Clearly articulate in the results and discussion sections how the qualitative themes help to confirm, challenge, or explain the quantitative findings. Consider using a joint display or matrix to demonstrate this integration explicitly. 2. Sampling and Representativeness: o The study claims to generalize to "females of reproductive age," but the sample is predominantly from the UK and appears to over-represent physically active women (e.g., 44.8% report >6 hours of exercise/week). This could bias perceptions of weight management and may not reflect the general population. o Recommendation: Discuss the sampling bias and its implications more clearly in the limitations section. Consider tempering generalizations and clarifying that findings may be most relevant to physically active, health-conscious populations. 3. Operationalization of “Weight Management Struggles”: o The manuscript heavily relies on participants’ self-reported struggles with weight loss or gain without defining how "struggle" was measured or whether this referred to actual weight change or subjective difficulty. o Recommendation: Provide clarity in the methods on how “struggle” was conceptualized and whether validated scales or anchor questions were used. Otherwise, the construct remains vague and open to interpretation. 4. Interpretation of DMPA-Related Weight Gain: o While DMPA is repeatedly identified as associated with weight gain, the discussion lacks nuance regarding dose, duration, and metabolic factors. The attribution is largely anecdotal and may reflect confirmation bias. o Recommendation: Strengthen this section by discussing the limitations of self-reported weight change, the potential for recall bias, and contrasting findings from prospective studies on DMPA. Consider the role of coexisting lifestyle changes. 5. Use of Social Ecological Model (SEM): o Although SEM is introduced as the framework, its application in the findings is inconsistent. The mapping of themes onto SEM levels (e.g., interpersonal, societal) seems forced at times and lacks theoretical depth. o Recommendation: Ensure that SEM is systematically applied across all themes with clearer justification. Avoid vague attributions (e.g., "societal level" for stress) and explain how each level influenced contraceptive perception and behavior. Minor Comments 1. Background in Introduction: o The introduction would benefit from a stronger contextual background on the significance of perceived weight changes in contraceptive users, especially linking this perception to contraceptive adherence and health outcomes. A more focused rationale would help set up the need for this mixed-methods study. 2. Study Location Missing in Abstract: o The abstract should clearly state where the study was conducted (e.g., United Kingdom). This adds context and helps readers assess the generalizability of findings. 3. Repeated References: o Some references appear more than once with minimal distinction (e.g., Brown & Clegg 2010a and 2010b; Gallo et al. 2014a and 2014b). Please check for redundancy and consolidate citations where appropriate. 4. Outdated Prevalence References: o The introduction cites contraceptive prevalence using data from older sources (e.g., WHO 2014, Alkema et al. 2013). Consider updating this with more recent national or global estimates (e.g., WHO or UNFPA 2022 reports). 5. Questionnaire Validation: o While pilot testing is mentioned, there is no clear description of how the questionnaire was validated. Was face validity or content validity assessed formally? Clarifying this would strengthen the reliability of the quantitative data. 6. Abbreviation Use (e.g., DMPA): o Ensure that all abbreviations are written out in full at first mention (e.g., “DMPA” should be “Depot Medroxyprogesterone Acetate (DMPA)” initially). This helps readers who are not familiar with contraceptive terminology. 7. Title Clarity: o The main title “Does it hold weight?” is catchy but somewhat vague. Consider adding a more descriptive subtitle to improve clarity (e.g., “Perceived Effects of Contraceptive Use on Weight in Females: A Mixed-Methods Study”). 8. Grammar and Formatting: o Minor grammatical issues and typographical errors are scattered throughout the manuscript (e.g., missing articles, extra spaces, inconsistent tenses). A thorough proofread is recommended. 9. Inconsistent Terminology: o The manuscript uses terms like “weight gain,” “weight status,” and “weight management struggles” interchangeably. These should be clearly defined and used consistently to avoid confusion. 10. Figures and Tables: • Figure references (e.g., “FIGURE 2 NEAR HERE”) appear as placeholders. Ensure figures are properly inserted, numbered, captioned, and clearly explained in the text. Table formatting could also be improved for clarity. 11. Use of First-Person Language: • Phrases such as “we are aware” appear in the manuscript. Consider revising these to maintain a neutral academic tone unless first-person language is permitted by journal guidelines. 12 Consider including basic inferential statistical analysis, such as calculating odds ratios or chi-square tests, to enhance the quantitative interpretation of survey findings. If appropriate, consult a statistician to strengthen the analytical rigor. Reviewer #2: Review Comments to the Author: Thank you for the opportunity to review this manuscript. The topic - perceived effects of contraceptive use on weight status in females - is both clinically relevant and timely, especially in the context of informed contraceptive choice and body image concerns among women. The authors have successfully applied a mixed - methods design to gain both breadth and depth in understanding women’s experiences. The integration of qualitative interviews, grounded in a socio - ecological model, provides valuable insight into the broader psychosocial and lifestyle factors that interact with contraceptive use and perceived weight changes. However, there are several important methodological and clinical issues that should be addressed to improve the clarity, rigor, and reproducibility of the study: Lifestyle Confounding Factors Not Assessed: The quantitative survey did not include questions about nutritional patterns (e.g., meal frequency, diet quality) or detailed physical activity classification (e.g., light/moderate/vigorous activity). These omissions are significant given the study’s focus on weight perception and management. No Objective Measures of Body Composition: The study relies entirely on self-reported weight-related perceptions without data on body composition (fat mass vs. muscle mass) or clinical indicators (e.g., presence of edema or fluid retention, which are common with some contraceptives). This limits the physiological interpretability of the findings. Missing Pharmacological Details: The manuscript does not specify which types of progestins were included in the combined oral contraceptives (COCs) used by participants. Since progestins have differing metabolic effects, this information is critical and should be reported. Clinical Inconsistency Not Addressed: One participant reportedly used COCs to stop migraines, which contradicts current clinical guidelines that contraindicate combined hormonal contraceptives in women with migraine-especially with aura - due to elevated stroke risk. This discrepancy should be clarified or contextualized. Anonymity of Qualitative Data: While the interview excerpts are rich and informative, some are highly personal and may allow participants to be identified. It should be clarified whether participants gave explicit consent for their quotations to be published. Recommendations for Revision: -Include specific details about contraceptive formulations (especially the progestins used). -Clarify ethical procedures regarding qualitative data publication. -Add discussion about the lack of objective anthropometric or clinical data (e.g., edema). -Consider a stronger discussion of lifestyle confounders and suggest their inclusion in future research tools. -Clarify or revise the mention of COC use for migraine management to align with safety guidelines. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-25-30751R1-->-->Does it hold weight? The perceived effects of contraceptive use on weight status in females: A Mixed-Methods Study-->-->PLOS ONE?> Dear Dr. Johnson, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 29 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Vandana Dabla Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Authors are requested to revise the manuscript as per reviewer's comments attached on the revision submitted. In addition, it is noteworthy that while the DMPA perceptions naturally arose in interviews and thus its inclusion is vital in the study results; there is no equal discussion of individual metabolic variability, the role of lifestyle, psychosocial factors and the benefits of DMPA itself. Thus, it may cause a moderate risk of misinterpretation to reader that DMPA universally causes weight gain (which neither is evidenced by the study, nor it is its objective). Hence, to ensure ethical neutrality and scientific fairness, the author should explicitly clarify that the "association is perceived, and is not established causally or any other biomedical evidence in the current study". Add explicit qualifiers distinguishing perceptions from evidence and may mention DMPA’s clinical safety/effectiveness in the discussion. Such ethical neutrality must be maintained throughout the manuscript, including recommendations. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: Terminology consistency: Ensure consistent use of terms like "weight management struggles," "weight gain," and "weight status." Clarify their operational definitions early in the Methods section. Clarify measures: Explicitly state how "struggles" were assessed – subjective reports, specific questions, or scales. Emphasize the perception-based nature and acknowledge this as a limitation. Formatting and language: Conduct a thorough proofreading to remove minor grammatical errors, ensure tense consistency, and adhere to journal style guidelines. Title and abstract: Consider adding a subtitle for clarity, for example, "A Mixed-Methods Study." Also, clearly state the study’s location (e.g., UK) in the abstract for context. References: Update any outdated references, remove duplicate citations, and ensure all are correctly formatted. Ethical statement: Clarify that participants consented explicitly for quotations and data publication, emphasizing confidentiality and anonymity processes. Additional minor points: Expand the discussion on limitations, especially regarding the sample's representativeness and potential biases. Elaborate briefly on the validation process of the questionnaire. Consistently define abbreviations at first mention (e.g., DMPA). ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
Does it hold weight? The perceived effects of contraceptive use on weight status in females: A Mixed-Methods Study PONE-D-25-30751R2 Dear Dr. Johnson, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Vandana Dabla Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-30751R2 PLOS One Dear Dr. Johnson, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Vandana Dabla Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .